The Hidden Costs: Assessing the Multi-Billion-Dollar Economic Burden in the US Neuropathic Pain Market Economic Outlook
The economic impact of neuropathic pain on the US healthcare system and wider economy is staggering, extending far beyond the direct costs of medications and procedures. The condition is a primary driver of healthcare resource utilization (HCRU), leading to frequent doctor visits, emergency room use, and inpatient admissions. Patients with chronic neuropathic pain consume disproportionately...
0 Commentarios 0 Acciones 485 Views 0 Vista previa